FTXH News and Press, First Trust Nasdaq Pharmaceuticals ETF From 09/23/21

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) - $0.0393. 30-Day SEC Yield of 0.61% as of Aug. 31. Payable Sep 30; for shareholders of record Sep 24; ex-div Sep 23. For further details see: First Trust Nasdaq Pharmaceuticals ETF declares quarterly distribution of $0.0393

We’ve seen economic data in recent months moderate after record growth in the first half of 2021. In financials, the rise of many fintech companies and the growth of digital payments has really disrupted the traditional banking industry, creating new options for consumers. ...

Defensive stocks are often misunderstood. In recent years, even when they have delivered strong and steady earnings, returns have disappointed. After a period of underperformance for defensives, a broadening market can represent real opportunity. Beyond utilities, we believe that ...

In any market’s upswing, there are always going to be people who make the case that “it’s different this time”, and historically, most of the time, that argument doesn’t hold up. I have never seen so many interesting and novel therapeutic opportuniti...

The best news last week was the continuing decline in global bond yields, including the 10-year Treasury rate falling below 1.4% last Tuesday. If and when the Fed decides to raise key short-term interest rates, I don’t think they will be able to raise rates by much, since the f...

First Trust Nasdaq Pharmaceuticals ETF (FTXH) - $0.0533.30-Day SEC Yield of 0.55% as of May 28.Payable Jun 30; for shareholders of record Jun 25; ex-div Jun 24. For further details see: First Trust Nasdaq Pharmaceuticals ETF declares quarterly distribution of $0.0533

From a consumer perspective, the consumer is actually now demanding a focus on environmental, social, governance factors. If public expectations for inflation do rise, that is going to be a change from years past. There’s going to be an opportunity to make medical progress ...

Opportunities and risks in the healthcare sector. The next big areas of innovation in healthcare. Extreme winners and losers in the healthcare sector. For further details see: Building A Healthy Portfolio: Spotlight On Healthcare

In January 2020, only 0.24% of total medical claims in the U.S. were telemedicine-related. One year later, they totaled 7%. It took 15 years for e-commerce penetration to rise from less than 1% to over 7%. The pandemic helped telemedicine do it in one. Population-wide immunity to ...

This has been a long, long boom in the amount of money that's flowed into this sector, and I don't think I've ever seen anything like it in my own career. This has been VC money going into early-stage startups, it's been IPOs, it's been follow-on financing of already public companies....